PUTRAJAYA — Malaysia and Australia reaffirm their commitment to strengthening women’s participation and leadership in science, technology and innovation (STI), particularly in high-growth sectors such as biotechnology, in building a more inclusive and competitive national innovation ecosystem. This commitment was highlighted in conjunction with the inaugural Malaysia–Australia Women in Biotechnology Luncheon, jointly organised by Australia’s Commonwealth...

Durham, N.C. —  AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the randomization of the last participant was completed earlier this year for GenePHIT, its Phase 2 clinical trial of AB-1002, an investigational gene therapy being developed as a potential treatment for...

WUHU, China — Chery Group’s new energy vehicle brand iCAUR announced that it will host its iCAUR International Business Summit from April 26 to April 28, 2026, during Auto China 2026, bringing together global partners, media, and industry stakeholders to present the next stage of its new energy strategy. The summit will serve not only as...

ZEISS recently unveiled the new ZEISS Crossbeam 750 focused ion beam-scanning electron microscope (FIB-SEM) that is optimized for demanding sample preparation. It provides a live, high-resolution “see while you mill” view at any imaging and milling condition to enable immediate feedback and eliminate milling interruptions for uniform first-pass transmission electron microscopy (TEM) lamellae and precise...

SYDNEY, Australia — Yesterday, premium wellness brand BON CHARGE™ launched its inaugural Global Wellness Tech Trend Report highlighting a rapid surge in popularity for wellness technologies, including red light therapy, blue light blocking devices, infrared sauna, and PEMF (Pulsed Electromagnetic Field therapy) tools. Based on a global survey of 7,000 adults across the U.S., UK, UAE, and Australia, the research...

AMSTERDAM, the Netherlands — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that assists physicians during one of interventional cardiology’s most technically demanding procedures – repairing leaking mitral valves through...